MEROPENEM - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for meropenem and what is the scope of patent protection?

Meropenem is the generic ingredient in four branded drugs marketed by Acs Dobfar, Acs Dobfar Spa, Amneal Pharms, Brooks Steriscience, Daewoong Pharm Co, Eugia Pharma, Gland, Hospira Inc, Hq Spclt Pharma, Qilu, Sandoz, Savior Lifetec Corp, Pfizer, B Braun Medical Inc, and Rempex, and is included in sixteen NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for meropenem. Fifteen suppliers are listed for this compound.

Sponsor	Phase
Scandinavian Critical Care Trials Group	Phase 4
Pisa University Hospital	Phase 4
Sheba Medical Center	Phase 4

Sponsor

Phase

Scandinavian Critical Care Trials Group

Phase 4

Pisa University Hospital

Phase 4

Sheba Medical Center

Phase 4

US Patents and Regulatory Information for MEROPENEM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eugia Pharma	MEROPENEM	meropenem	INJECTABLE;INJECTION	205835-002	Mar 27, 2017	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Rempex	VABOMERE	meropenem; vaborbactam	POWDER;INTRAVENOUS	209776-001	Aug 29, 2017		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
B Braun Medical Inc	MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER	meropenem	POWDER;INTRAVENOUS	202106-001	Apr 30, 2015		RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
B Braun Medical Inc	MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER	meropenem	POWDER;INTRAVENOUS	202106-002	Apr 30, 2015		RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	MERREM	meropenem	INJECTABLE;INJECTION	050706-001	Jun 21, 1996	⤷ Sign Up	⤷ Sign Up
Pfizer	MERREM	meropenem	INJECTABLE;INJECTION	050706-003	Jun 21, 1996	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

INJECTABLE;INJECTION

Jun 21, 1996

⤷ Sign Up

INJECTABLE;INJECTION

Jun 21, 1996

⤷ Sign Up

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Sign Up

US Patents:	7
Tradenames:	4
Applicants:	15
NDAs:	16
Drug Master File Entries:	32
Finished Product Suppliers / Packagers:	15
Raw Ingredient (Bulk) Api Vendors:	84
Clinical Trials:	137
Patent Applications:	5,925
Drug Prices:	Drug price trends for MEROPENEM
What excipients (inactive ingredients) are in MEROPENEM?	MEROPENEM excipients list
DailyMed Link:	MEROPENEM at DailyMed

MEROPENEM - Generic Drug Details

What are the generic sources for meropenem and what is the scope of patent protection?

Summary for MEROPENEM

Recent Clinical Trials for MEROPENEM

Pharmacology for MEROPENEM

Anatomical Therapeutic Chemical (ATC) Classes for MEROPENEM

US Patents and Regulatory Information for MEROPENEM

Expired US Patents for MEROPENEM

Make Better Decisions: Try a trial or see plans & pricing